Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Primaquine Enantiomers in Healthy Volunteers
NCT03934450Phase 1Completed
- Sponsor
- University of Mississippi
- Start
- Aug 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of R-primaquine and SPQ in malaria (4 arms), sponsored by University of Mississippi. Primary endpoint: Change in Methemoglobin concentration in blood from baseline. Started Aug 2018; status: completed.
02
Drugs
R-primaquineSPQ
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03934450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03934450.